Experience of recombinant activated factor VII usage during surgery in patients with haemophilia with inhibitors

Haemophilia

Volumn 18, Issue 6, 2012, Pages 997-1002

  Polyanskaya, T ^a   Zorenko, V ^a   Karpov, E ^a   Sampiev, M ^a   Mishin, G ^a   Vasiliev, D ^a  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

Author keywords

Haemophilia; Inhibitor; NovoSeven ; rFVIIa; Surgery

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIFAMPICIN;

ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; HEMOPHILIA A; HIP OSTEOTOMY; HUMAN; KNEE ENDOPROSTHESIS; LEG AMPUTATION; MEDICAL RECORD REVIEW; ORTHOPEDIC SURGERY; OSTEOSYNTHESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHILD; FACTOR VIIA; FACTOR VIII; HEMOPHILIA A; HEMORRHAGE; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84868200291     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02866.x     Document Type: Article

References (22)

1. McMillan CW, Shapiro SS, Whitehurst D, Hoyer LW, Rao AV, Lazerson J. The natural history of factor VIII:C inhibitors in patients with hemophilia A. a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors. Blood 1988; 71: 344-8.
2. Ehrenforth S, Kreuz W, Scharrer I et al.Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992; 339: 594-8.
3. Hay CR, Baglin TP, Collins PW, Hill FG, Keeling DM. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). Br J Haematol 2000; 111: 78-90.
4. Ljung R, Petrini P, Tengborn L, Sjörin E. Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity. Br J Haematol 2001; 113: 81-6.
5. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003; 9: 418-35.
6. Kulkarni R, Aledort LM, Berntorp E et al.Therapeutic choices for patients with hemophilia and high-titer inhibitors. Am J Hematol 2001; 67: 240-6.
7. Andreev YN. Many-sided hemophilia. Monography. Moscow, Njudiamed, 2006: 215.
8. Yu Polyanskaya T, Khametova RN, Yu Andreev N. Development and clinical course of hemophilia complicated by the presence of an inhibitor. Haematol Transfusiol 2002; 47: 9-12.
9. Nilsson IM, Berntorp E, Freiburghaus C. Treatment of patients with factor VIII and IX inhibitors. Thromb Haemost 1993; 70: 56-9.
10. White GC 2nd, Taylor RE, Blatt PM, Roberts HR. Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a case. Blood 1983; 62: 141-5.
11. Abildgaard CF, Penner JA, Watson-Williams EJ. Anti-inhibitor coagulant complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia. Blood 1980; 56: 978-84.
12. Lozier JN, Santagostino E, Kasper CK, Teitel JM, Hay CR. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Semin Hematol 1993; 30(2 Suppl 1): 10-21.
13. Hvid I, Soballe K, Ingerslev J. Elective orthopaedic surgery in haemophilia patients with high-responding inhibitors. In: Rodriguez-Merchan EC, Lee CA eds. Inhibitors in Patients with Haemophilia. Part 6. Musculoskeletal issues. Oxford, UK: Blackwell Science Ltd., 2002: 169-78.
14. Hedner U, Glazer S, Pingel K et al. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet 1988; 2: 1193.
15. Faradji A, Bonnomet F, Lecocq J et al.Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature. Haemophilia 2001; 7: 321-6.
16. Saba HI, Morelli GA, Azam RR, Klein CJ, Letson GD. Efficacy of NovoSeven during surgery on a haemophiliac with previous history of inhibitors. Haemophilia 2003; 9: 131-6.
17. NovoSeven® RT Prescribing Information. Available at http://www.novosevenrt.com/pdfs/PI_novosevenrt.pdf. Accessed November 23, 2011.
18. Mironov S, Kotelnikov G. A national management. Moscow, 2008.
19. Fernandez-Palazzi F, Rivas S, Viso R, de Bosch NB, de Saez AR, Boadas A. Synovectomy with rifampicine in haemophilic haemarthrosis. Haemophilia 2000; 6: 562-5.
20. Chemis AG. Synoviorthesis with rifampicin in the treatment of chronic synovitis in hemophiliacs. Haematol Transfusiol 2002; 47: 18-9.
21. Sadykova NV, Chemis AG, Mamonov VE, Zorenko VY, Ryashencev MM. The direct and remote results sinovectomy with rifampicin in the patients with hemophilia. Hematol Blood Transfusion Prob 2005; 1: 7-11.
22. Rodríguez-Merchán EC. Management of the orthopaedic complications of haemophilia. J Bone Joint Surg Br 1998; 80: 191-6.